Immunic (NASDAQ:IMUX) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement.
Analysts estimate that Immunic will report an earnings per share (EPS) of $-0.66.
SVB Leerink has downgraded Immunic Inc (NASDAQ:IMUX) to Market Perform from Outperform following disappointing initial data from the highly anticipated Phase 1b proof-of-concept…